Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Matas

Showing results (11-20 of 481) with videos related to

Pageof 49
Sort By:
Canadian Journal of Microbiology|November 1, 1981
Solubilization of microsomal-associated phosphatidylserine synthase and phosphatidylinositol synthase from Saccharomyces cerevisiaeG M Carman, J Matas
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 17, 2002
Long-term (20-37 years) follow-up of living kidney donorsThiagarajan Ramcharan, Arthur J Matas
Seminars in Dialysis|January 10, 2006
Surgical complications after kidney transplantationAbhinav Humar, Arthur J Matas
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 13, 2007
The current role of calcineurin inhibitors in posttransplant immunosuppression?A J Matas, R Kandaswamy
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2004
Payment for living donor (vendor) kidneys: a cost-effectiveness analysisArthur J Matas, Mark Schnitzler
Mayo Clinic Proceedings|October 10, 2022
Long-term Medical Outcomes of Living Kidney DonorsArthur J Matas, Andrew D Rule
Critical Care Clinics|October 1, 1990
Renal transplantationD J Frey, A J Matas
Clinical Journal of the American Society of Nephrology : CJASN|July 2, 2013
The unjustified classification of kidney donors as patients with CKD: critique and recommendationsArthur J Matas, Hassan N Ibrahim
Clinical Transplantation|July 17, 2019
Prednisone-free maintenance immunosuppression in obese kidney transplant recipientsArthur J Matas, David M Vock
Clinical Transplantation|February 25, 2017
Living donor kidney allograft survival ≥ 50 yearsOscar K Serrano, Arthur J Matas
Pageof 49

Showing results (11-20 of 481) with videos related to

Sort By:
Pageof 49
Canadian Journal of Microbiology|November 1, 1981
Solubilization of microsomal-associated phosphatidylserine synthase and phosphatidylinositol synthase from Saccharomyces cerevisiaeG M Carman, J Matas
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 17, 2002
Long-term (20-37 years) follow-up of living kidney donorsThiagarajan Ramcharan, Arthur J Matas
Seminars in Dialysis|January 10, 2006
Surgical complications after kidney transplantationAbhinav Humar, Arthur J Matas
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 13, 2007
The current role of calcineurin inhibitors in posttransplant immunosuppression?A J Matas, R Kandaswamy
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2004
Payment for living donor (vendor) kidneys: a cost-effectiveness analysisArthur J Matas, Mark Schnitzler
Mayo Clinic Proceedings|October 10, 2022
Long-term Medical Outcomes of Living Kidney DonorsArthur J Matas, Andrew D Rule
Critical Care Clinics|October 1, 1990
Renal transplantationD J Frey, A J Matas
Clinical Journal of the American Society of Nephrology : CJASN|July 2, 2013
The unjustified classification of kidney donors as patients with CKD: critique and recommendationsArthur J Matas, Hassan N Ibrahim
Clinical Transplantation|July 17, 2019
Prednisone-free maintenance immunosuppression in obese kidney transplant recipientsArthur J Matas, David M Vock
Clinical Transplantation|February 25, 2017
Living donor kidney allograft survival ≥ 50 yearsOscar K Serrano, Arthur J Matas
Pageof 49